LUKE M BESHAR
CIK 1192128 · EVP & CFO · last filed 2026-06-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$929.6K
Companies
5
Total Filings
67
Lifetime Open-Market Net
-$17.22M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TARA | Director | 198,000 | $3.98 | $788.0K | $118.1K | 12 | 2026-06-16 |
| Omega Therapeutics, Inc. (OMGA) Delisted | Director | — | $0.14 | — | $0 | 3 | 2023-06-09 |
| RGNX | Director | 12,784 | $11.07 | $141.5K | -$4.18M | 11 | 2021-06-08 |
| NPS PHARMACEUTICALS INC (NPSP) Delisted | EVP & CFO | 0 | — | — | -$12.66M | 34 | 2015-02-24 |
| CAMBREX CORP (CBM) Delisted | Executive Vice President | 0 | — | — | -$497.0K | 6 | 2007-10-12 |
Recent Filings · Page 4 of 7
67 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-12-19 | NPS PHARMACEUTICALS INC (NPSP) Delisted | Mixed | — | -$1.46M | EDGAR |
| 2014-11-19 | NPS PHARMACEUTICALS INC (NPSP) Delisted | Mixed | — | -$1.20M | EDGAR |
| 2014-11-04 | NPS PHARMACEUTICALS INC (NPSP) Delisted | Sell (S) | −10,000 | -$290.0K | EDGAR |
| 2014-10-29 | NPS PHARMACEUTICALS INC (NPSP) Delisted | Sell (S) | −30,635 | -$819.6K | EDGAR |
| 2014-08-15 | NPS PHARMACEUTICALS INC (NPSP) Delisted | Exer (M) | +53,813 | $185.9K | EDGAR |
| 2014-02-14 | NPS PHARMACEUTICALS INC (NPSP) Delisted | Mixed | +5,071 | -$209.1K | EDGAR |
| 2014-02-11 | NPS PHARMACEUTICALS INC (NPSP) Delisted | Mixed | +4,318 | -$163.3K | EDGAR |
| 2014-01-09 | NPS PHARMACEUTICALS INC (NPSP) Delisted | Mixed | — | -$1.00M | EDGAR |
| 2013-12-30 | NPS PHARMACEUTICALS INC (NPSP) Delisted | Mixed | — | -$941.2K | EDGAR |
| 2013-12-16 | NPS PHARMACEUTICALS INC (NPSP) Delisted | Mixed | — | -$951.7K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.